Measurement of fibroblast proliferative activity in bronchoalveolar lavage fluid in the analysis of obliterative bronchiolitis among lung transplant recipients.

[1]  M. Estenne,et al.  Obliterative bronchiolitis after lung transplantation , 2000, Current opinion in pulmonary medicine.

[2]  H. Shennib,et al.  A novel charcoal-induced model of obliterative bronchiolitis-like lesions: implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis. , 1998, The Journal of thoracic and cardiovascular surgery.

[3]  G. Patterson,et al.  HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. , 1998, Transplantation.

[4]  P. Grenier,et al.  Expiratory CT scans for chronic airway disease: correlation with pulmonary function test results. , 1998, AJR. American journal of roentgenology.

[5]  G. Patterson,et al.  Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  R. Bolman,et al.  Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. , 1997, The Journal of thoracic and cardiovascular surgery.

[7]  T. McLoud,et al.  Correlation of high-resolution CT and pulmonary function in bronchiolitis obliterans: a study based on 24 patients associated with consumption of Sauropus androgynus. , 1997, AJR. American journal of roentgenology.

[8]  K. Beck,et al.  Posttransplantation physiologic features of the lung and obliterative bronchiolitis. , 1997, Mayo Clinic proceedings.

[9]  G. Berry,et al.  Risk factors for the development of obliterative bronchiolitis after lung transplantation. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  F. Martinez,et al.  Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. , 1996, Journal of immunology.

[11]  G. Berry,et al.  Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. , 1996, The Annals of thoracic surgery.

[12]  Mauck Ka,et al.  The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. , 1996 .

[13]  J. Golden,et al.  Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects , 1996, Antimicrobial agents and chemotherapy.

[14]  J. Dauber.  Posttransplant bronchiolitis obliterans syndrome. Where have we been and where are we going? , 1996, Chest.

[15]  S. Nathan,et al.  Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials. , 1996, Chest.

[16]  L. Garbe,et al.  Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montréal Lung Transplantation Group. , 1996, American journal of respiratory and critical care medicine.

[17]  G. Berry,et al.  Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  S. Yousem,et al.  Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients. , 1996, Human pathology.

[19]  A. Husain,et al.  Bronchiolar basement membrane changes associated with bronchiolitis obliterans in lung allografts: a retrospective study of serial transbronchial biopsies with immunohistochemistry [corrected]. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  L. Sharples,et al.  Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors. , 1996, Transplantation.

[21]  G. Berry,et al.  Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  J. Theodore,et al.  Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  G. Patterson,et al.  Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation , 1995 .

[24]  B. Griffith,et al.  Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. , 1995, The Journal of thoracic and cardiovascular surgery.

[25]  M. Elices,et al.  Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. , 1995, The Journal of clinical investigation.

[26]  J. Golden,et al.  Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin , 1995, Antimicrobial agents and chemotherapy.

[27]  M. B. King,et al.  Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived growth factor and basic fibroblast growth factor. , 1995, Transplantation.

[28]  L. Garbe,et al.  Monitoring of alveolar macrophage production of tumor necrosis factor-alpha and interleukin-6 in lung transplant recipients. Marseille and Montreal Lung Transplantation Group. , 1994, American journal of respiratory and critical care medicine.

[29]  W. Webb,et al.  Dynamic Quantitative Computed Tomography: A Predictor of Pulmonary Function in Obstructive Lung Diseases , 1994, Investigative radiology.

[30]  J. B. Winter,et al.  Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts. , 1994, Transplantation.

[31]  G. Patterson,et al.  Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group. , 1994, The Journal of thoracic and cardiovascular surgery.

[32]  B. Griffith,et al.  Airway obstruction and bronchiolitis obliterans after lung transplantation. , 1993, Clinics in chest medicine.

[33]  P. Huie,et al.  Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. , 1993, Transplantation.

[34]  M. B. King,et al.  Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. , 1993, The American journal of pathology.

[35]  R. Nakhleh,et al.  Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Akselband,et al.  Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. , 1991, Transplantation proceedings.

[37]  K. Tani,et al.  Thrombin enhances lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. , 1991, American journal of respiratory cell and molecular biology.

[38]  C. Turck,et al.  Reduction in pulmonary fibroblast-stimulating activity as an index of response to treatment of interstitial lung diseases. , 1990, The New England journal of medicine.

[39]  J. Maurer,et al.  Long-term functional follow-up of lung transplant recipients. , 1990, Clinics in chest medicine.

[40]  T. King,et al.  Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method. , 1988, The American review of respiratory disease.

[41]  D. Aberle,et al.  Asbestos exposure-cigarette smoking interactions among shipyard workers. , 1988, JAMA.

[42]  J. Golden,et al.  Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome. , 1986, Chest.

[43]  V. Ferrans,et al.  Accurate quantification of cells recovered by bronchoalveolar lavage. , 1984, The American review of respiratory disease.

[44]  W. Webb,et al.  Inhomogeneous lung attenuation at thin-section CT: diagnostic value of expiratory scans. , 1998, Radiology.

[45]  G. Patterson,et al.  A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  Stern Ej,et al.  Dynamic imaging of lung morphology with ultrafast high-resolution computed tomography. , 1993 .